• Research
    • Research groups
    • Functional Genomics Area
    • Strategic Line 1: The Human Genome
    • Strategic Line 2: Cancer Genomics
    • Personalised Medicine Area
    • Strategic Line 3: Detection, Diagnostics, Monitoring and Prognostics of Diseases
    • Strategic Line 4: Advanced Therapies
    • Publications
    • International Projects

There are no projects in the garbage can.

  • WebMail
  • Private area
  • Center
    • What is GENyO?
    • Support Units
    • Management Units
    • Strategic Plan 2024-2027
    • Transparency
    • Contact
  • Events and news
    • News
    • Events
    • Scientific Conferences
    • Galleries
  • GENyO TV
  • Research
    • Research groups
    • Functional Genomics Area
    • Strategic Line 1: The Human Genome
    • Strategic Line 2: Cancer Genomics
    • Personalised Medicine Area
    • Strategic Line 3: Detection, Diagnostics, Monitoring and Prognostics of Diseases
    • Strategic Line 4: Advanced Therapies
    • Publications
    • International Projects
  • Center
    • What is GENyO?
    • Support Units
    • Management Units
    • Strategic Plan 2024-2027
    • Transparency
    • Contact
  • Events and news
    • News
    • Events
    • Scientific Conferences
    • Galleries
  • GENyO TV
  • WebMail
  • Private area

There are no projects in the garbage can.

The Canal Sur programme ‘ConCiencia’ interviews GENyO researchers Verónica Ramos and Sara R. Heras

Posts and news

News

23 de May de 2025

The Canal Sur programme ‘ConCiencia’ interviews GENyO researchers Verónica Ramos and Sara R. Heras

Canal Sur’s ‘ConCiencia’ interviewed Verónica Ramos Mejía about advances in the field of childhood cancer research and Sara Rodríguez Heras...

See news

Home - News - Sin categoría - Page 2

  • All the news
  • 2025
Project LOLA promotes the use of liquid biopsies to improve cancer diagnosis and treatment in Andalusia.

23 de May de 2025

Project LOLA promotes the use of liquid biopsies to improve cancer diagnosis and treatment in Andalusia.

Project LOLA (Liquid Biopsy, Lung and Colon Cancer in Andalusia), which is coord...

Investigadores de GENyO avanzan en la predicción de supervivencia en Leucemia Mieloide Aguda Pediátrica a través de microRNAs

23 de May de 2025

Investigadores de GENyO avanzan en la predicción de supervivencia en Leucemia Mieloide Aguda Pediátrica a través de microRNAs

The research offers a new predictive model based on the expression of microRNAs, which co...

GENyO and UGR researchers are recognised in Nature Portfolio special collection following the Nobel Prize in Physiology or Medicine 2024 for microRNAs

23 de May de 2025

GENyO and UGR researchers are recognised in Nature Portfolio special collection following the Nobel Prize in Physiology or Medicine 2024 for microRNAs

To celebrate the 2024 Nobel Prize in Physiology or Medicine that has been awarded for the...

A study by GENyO researchers reveals new epigenetic changes in Systemic Lupus Erythematosus.

23 de May de 2025

A study by GENyO researchers reveals new epigenetic changes in Systemic Lupus Erythematosus.

A new study from the PRECISEADS project reveals how molecular stratification of patients with Sy...

GENyO participates in the European Researchers’ Night 2024

23 de May de 2025

GENyO participates in the European Researchers’ Night 2024

GENyO in Granada, joins again this event with a series of activities, following the tradition of...

GENyO celebra UniStem Day, una jornada internacional sobre células madre

23 de May de 2025

GENyO celebra UniStem Day, una jornada internacional sobre células madre

GENyO is hosting UniStem Day at its facilities on Friday 22 March 2024, a day dedicated exclusiv...

Dr. Marta Alarcón Riquelme, new scientific director of GENyO

23 de May de 2025

Dr. Marta Alarcón Riquelme, new scientific director of GENyO

The Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncology Research (...

GENyO hosts the first NanoCARE 2.0 Network course

23 de May de 2025

GENyO hosts the first NanoCARE 2.0 Network course

The Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncology Research (...

Página 2 de 2«12

    Transparency

  • Documents of interest
  • Organizational structure
  • Organizational chart

    Research

  • Research groups
  • Functional Genomics Area
  • Personalised Medicine Area
  • International Projects
  • Publications

    Center

  • What is GENyO?
  • Support Units
  • Management Units
  • Strategic Plan 2024-2027
  • Transparency
  • Contact

    Events and news

  • News
  • Events
  • Scientific Conferences
  • Galleries

Address

Avda. de la Ilustración 114.
18016 Granada, Spain

+34 958 715 500
info@genyo.es
  • Company affiliation

    2025 @Genyo All rights reserved

  • Legal note
  • Cookies Policy
  • Privacy Policy
Manage consent

In GENyO we use own and third party cookies to perform usage analysis and measurement of our website to obtain statistical data of your navigation and advertising. More information in our cookies policy

Functional Always active
The storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The storage or technical access is necessary for the legitimate purpose of storing preferences not requested by the subscriber or user.
Statistics
Technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a request, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
The storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or multiple websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
Configure
{title} {title} {title}